Transforming growth factor-alpha expression in human renal cell carcinoma: TGF-α expression in renal cell carcinoma

Urology

Volumn 47, Issue 1, 1996, Pages 29-33

  Hise, Michael K ^a   Jacobs, Stephen C ^b   Papadimitriou, John C ^b   Drachenberg, Cinthia I ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; PRIORITY JOURNAL; STAINING;

EID: 0030049964     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(99)80377-x     Document Type: Article

References (22)

1. Nouwen EJ, and De Broe ME: EGF and TGF-α in the human kidney: identification of octopal cells in the collecting duct. Kidney Int 45: 1510-1521, 1994.
2. Schreiber AB, Winkler ME, and Derynck R: Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250-1253, 1986.
3. Smith JJ, Derynck R, and Korc M: Production of transforming growth factor-α in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84: 7567-7570, 1987.
4. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, and Di Fiore PP: Autocrine interaction between TGF-α and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-838, 1989.
5. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens, in Richardson CC, Boyer PD, Dawid IB, and Meister A (Eds): Ann Rev Biochem. Palo Alto, Annual Review Inc, 1987, pp 881-914.
6. Behrens MT, Corbin AL, and Rise MK: Epidermal growth factor receptor regulation in rat kidney: two models of renal growth. Am J Physiol 257 (6 pt 2): F1059-F1064, 1989.
7. Wenczak BA, Lynch JB, and Nanney LB: Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J Clin Invest 90: 2392-2401, 1992.
8. Toma JG, Pareek S, Barker P, Mathew TC, Murphy RA, Acheson A, and Miller FD: Spatiotemporal increases in epidermal growth factor receptors following peripheral nerve injury. J Neurosci 12: 2504-2515, 1992.
9. Tarnawski A, Stachura J, Durbin T, Sarfeh IJ, and Gergely H: Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 102: 695-698, 1992.
10. Ambs KE, Takahashi A, Hering F, Costa S, and Huber PR: Epidermal growth factor receptor in adenocarcinoma of the kidney. Urol Res 17: 251-254, 1989.
11. Yoshida K, Tosaka A, Takeuchi S, and Kobayashi N: Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 73: 1913-1918, 1994.
12. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, and Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 48: 137-141, 1988.
13. Sainsbury JR, Malcolm AJ, Appleton DR, Farndon JR, and Harris AL: Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38: 1225-1228, 1985.
14. Rios MA, Macias A, Perez R, Lage A, and Skoog L: Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res 8: 173-176, 1988.
15. Real FX, Rettig WJ, Chesa PG, Melamed MR, Old LJ, and Mendelson J: Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res 46: 4726-4731, 1986.
16. Comella LG, Sargent ER, Wade TP, Anglard P, Lineban WM, and Kasid A: Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and betal in renal cell carcinoma. Cancer Res 49: 6972-6975, 1989.
17. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WD, and Fair WR: Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49: 3407-3411, 1989.
18. Sene AP, Hunt L, McMahon RF, and Carroll RN: Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70: 125-134, 1992.
19. Amtrup F, Hansen JB, and Thybo E: Prognosis in renal carcinoma evaluated from histological criteria. Scand J Urol Nephrol 8: 198-202, 1974.
20. Kay S: Renal carcinoma. A 10 year study. Am J Clin Pathol 50: 428-432, 1968.
21. Nakamoto T, Usui A, Oshima K, Ikemoto H, Mitani S, and Usui T: Analysis of growth factors in renal cell carcinoma. Biochem Biophys Res Commun 153: 818-824, 1988.
22. Petrides PE, Bock S, Bovens J, Hofmann R, and Jakse G: Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res 50: 3934-3939, 1990.